Consideration of viral resistance for optimization of direct antiviral therapy of hepatitis C virus genotype 1-infected patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS One, volume 10, issue 8, e0134395 (2015)
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Univ.-Bibliothek Frankfurt am Main
- (when)
-
2015
- Contributor
- URN
-
urn:nbn:de:hebis:30:3-390465
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:54 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dietz, Julia
- Susser, Simone
- Berkowski, Caterina
- Perner, Dany
- Zeuzem, Stefan
- Sarrazin, Christoph
- Univ.-Bibliothek Frankfurt am Main
Time of origin
- 2015
Other Objects (12)
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients
Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients
Ribavirin: current role in the optimal clinical management of chronic hepatitis C
Overcoming the roadblocks in hepatitis C virus infection
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients
Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients
Ribavirin: current role in the optimal clinical management of chronic hepatitis C
Overcoming the roadblocks in hepatitis C virus infection
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients
Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients
Ribavirin: current role in the optimal clinical management of chronic hepatitis C